| Literature DB >> 35799715 |
Mudasser Adnan1, Muhammad Sohail Arshad2, Hafiz Anwar-Ul-Haq3, Hashim Raza4.
Abstract
Objectives: To report trends in bacteriological spectrum and antibiotic susceptibility on blood culture in admitted pediatric cardiac patients at a Tertiary Childcare Health Facility.Entities:
Keywords: Acinetobacter baumannii; Blood culture; Salmonella typhi
Year: 2022 PMID: 35799715 PMCID: PMC9247796 DOI: 10.12669/pjms.38.5.5072
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 2.340
Distribution of Types of Stains Found (n=154).
| Types of Stains | Number (%) |
|---|---|
| Gram Positive Rods | 2 (1.3%) |
| Gram Positive Cocci | 43 (27.9%) |
| Gram Negative Rods | 69 (44.8%) |
| Gram Negative Cocci | 17 (11.0%) |
| Yeast Cells | 23 (14.9%) |
Frequency and Distribution of Bacterial Isolates with respect to Age Groups (n=131).
| Types of Bacterial Isolates | Number (%) | Age Groups (years) | |||
|---|---|---|---|---|---|
|
| |||||
| <1 | 1-5 | 5-10 | >10 | ||
|
| 30 (22.9%) | 22 | 3 | 2 | 3 |
| Acinetobacter Baumannii | 16 (12.2%) | 12 | 2 | 1 | 1 |
| Coagulase Negative Staphylococcus | 18 (13.7%) | 13 | 2 | 2 | 1 |
| Staphylococcus Epidermidis | 16 (12.2%) | 12 | 1 | 2 | 1 |
| Serratia Marcescens | 12 (9.1%) | 10 | 1 | - | 1 |
| Klebsiella Pneumoniae | 6 (4.6%) | 4 | 1 | - | 1 |
| Burkholderia SPP | 5 (3.8%) | 3 | 2 | - | - |
| Enterobacter Cloacae | 4 (3.1%) | 3 | 1 | - | - |
| Enterococcus Faecalis | 3 (2.3%) | 2 | - | 1 | - |
| Acenetobacter Lwoffii | 2 (1.5%) | 1 | 1 | ||
| Bacillus SPP | 2 (1.5%) | 2 | - | ||
| Eschericia Coli | 2 (1.5%) | 1 | 1 | ||
| Methicillin Resistant Staphylococcus Aureus | 2 (1.5%) | 1 | 1 | - | |
| Pseudomonas Aeruginosa | 2 (1.5%) | 1 | 1 | - | |
| Pseudomonas Luteola | 2 (1.5%) | - | 1 | 1 | - |
| Serratia Liquefaciens | 2 (1.5%) | 1 | 1 | - | |
| Others | 7 (5.3%) | 1 | 3 | 2 | 1 |
|
| |||||
| Total | 131 (100%) | 89 | 18 | 13 | 11 |
Antimicrobial Sensitivity and Resistance Patterns against Most Frequent Bacterial Isolates.
| Bacterial Isolate | Most Sensitive Antibiotic | Sensitivity (%) | Most Resistant Antibiotic | Resistance (%) |
|---|---|---|---|---|
| Meropenem | 93.3 | Chloramphenicol | 80.0 | |
| Imipenem | 86.7 | Ciprofloxacin | 80.0 | |
| Cefepime | 70.0 | Co-trimoxazole | 66.7 | |
| Ceftriaxone | 66.7 | Ampicillin | 50.0 | |
| Acinetobacter Baumannii (n=16) | Tigecyclin | 100 | Clindamycin | 100 |
| Colistin | 100 | Cefepime | 81.8 | |
| Chloramphenicol | 100 | Piperacillin Tazobactam | 81.3 | |
| Tobramycin | 90 | Ceftazidime | 81.3 | |
| Coagulase Negative Staphylococcus (n=18) | Amikacin | 100 | Azithromycin | 100 |
| Teicoplanin | 100 | Oxacillin | 83.3 | |
| Vancomycin | 100 | Tigecyclin | 69.2 | |
| Doxycyclin | 87.5 | Ciprofloxacin | 50 | |
| Staphylococcus Epidermidis (n=16) | Amikacin | 100 | Ampicillin | 100 |
| Vancomycin | 100 | Amoxicillin | 100 | |
| Linezolid | 93.8 | Co-Amoxiclav | 87.5 | |
| Doxycycline | 77.8 | Cefepime | 87.5 | |
| Serratia Marcescens (n=12) | Polymixin | 100 | Co-Amoxiclave | 100 |
| Fosfomycin | 100 | Piperacillin Tazobactam | 91.7 | |
| Amikacin | 58.3 | Cefotaxime | 91.7 | |
| Clindamycin | 55.6 | Doxycyclin | 83.3 | |
| Klebsiella Pneumoniae (n=6) | Tigecyclin | 100 | Clindamycin | 100 |
| Polymixin | 100 | Co-Amoxiclav | 83.3 | |
| Colistin | 100 | Cefotaxime | 80 | |
| Chloramphenicol | 100 | Doxycyclin | 80 |